Time to negative throat culture following initiation of antibiotics for pharyngeal group A Streptococcus: a systematic review and meta-analysis up to October 2021 to inform public health control measures
Open Access
- 13 April 2023
- journal article
- review article
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 28 (15) , 2200573
Abstract
Background: Public health guidance recommending isolation of individuals with group A streptococcal (GAS) infection or carriage for 12–24 h from antibiotic initiation to prevent onward transmission requires a strong evidence base. Aim: To estimate the pooled proportion of individuals who remain GAS culture-positive at set intervals after initiation of antibiotics through a systematic literature review (PROSPERO CRD42021290364) and meta-analysis. Methods: We searched Ovid MEDLINE (1946–), EMBASE (1974–) and Cochrane library. We included interventional or observational studies with ≥ 10 participants reporting rates of GAS throat culture positivity during antibiotic treatment for culture-confirmed GAS pharyngitis, scarlet fever and asymptomatic pharyngeal GAS carriage. We did not apply age, language or geographical restrictions. Results: Of 5,058 unique records, 43 were included (37 randomised controlled studies, three non-randomised controlled trials and three before-and-after studies). The proportion of individuals remaining culture-positive on day 1, day 2 and days 3–9 were 6.9% (95% CI: 2.7–16.8%), 5.4% (95% CI: 2.1–13.3%) and 2.6% (95% CI: 1.6–4.2%). For penicillins and cephalosporins, day 1 positivity was 6.5% (95% CI: 2.5–16.1%) and 1.6% (95% CI: 0.04–42.9%), respectively. Overall, for 9.1% (95% CI: 7.3–11.3), throat swabs collected after completion of therapy were GAS culture-positive. Only six studies had low risk of bias. Conclusions: Our review provides evidence that antibiotics for pharyngeal GAS achieve a high rate of culture conversion within 24 h but highlights the need for further research given methodological limitations of published studies and imprecision of pooled estimates. Further evidence is needed for non-beta-lactam antibiotics and asymptomatic individuals.Keywords
This publication has 90 references indexed in Scilit:
- Guidelines for prevention and control of group A streptococcal infection in acute healthcare and maternity settings in the UKJournal of Infection, 2012
- Once-daily amoxicillin versus twice-daily penicillin V in group A -haemolytic streptococcal pharyngitisArchives of Disease in Childhood, 2008
- Treatment of streptococcal pharyngitis with amoxycillin once a day.BMJ, 1993
- Comparative study of clarithromycin and penicillin V in the treatment of streptococcal pharyngitisEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Evaluation of two methods for overcoming the antibiotic carry-over effectEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Cefadroxil versus penicillin in the treatment of streptococcal tonsillopharyngitisEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- A Comparison of Cefadroxil and Penicillin V in the Treatment of Streptococcal Pharyngitis in ChildrenDrugs, 1986
- Effect of antibiotic therapy on the clinical course of streptococcal pharyngitisThe Journal of Pediatrics, 1985
- Cephalexin: Treatment of streptococcal pharyngitisThe Journal of Pediatrics, 1972
- Comparison of efficacy of phenoxymethylpenicillin and buffered penicillin G in treatment of streptococcal pharyngitisThe Journal of Pediatrics, 1966